Drug shortage
Pemetrexed Disodium Injection · Eli Lilly and Co.
FDA drug shortage · To Be Discontinued · updated Oct 16, 2025
Key facts
| Generic name | Pemetrexed Disodium Injection |
|---|---|
| Company | Eli Lilly and Co. |
| Presentation | Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 0002-7640-01 |
| First posted | Oct 16, 2025 |
| Last updated | Oct 16, 2025 |
| Discontinued | Oct 16, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: